281 related articles for article (PubMed ID: 15225468)
1. Emerging drug--resistance and guidelines for treatment of malaria.
Khan MA; Smego RA; Razi ST; Beg MA
J Coll Physicians Surg Pak; 2004 May; 14(5):319-24. PubMed ID: 15225468
[TBL] [Abstract][Full Text] [Related]
2. [Drug resistant tropical malaria in the Republic of Guinea (West Africa)].
Popov AF; Popova NI; Chirkov VP; Kamara F
Med Parazitol (Mosk); 2003; (2):41-3. PubMed ID: 12886592
[No Abstract] [Full Text] [Related]
3. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
4. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam.
Thanh NV; Cowman AF; Hipgrave D; Kim TB; Phuc BQ; Cong LD; Biggs BA
Trans R Soc Trop Med Hyg; 2001; 95(5):513-7. PubMed ID: 11706663
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
[TBL] [Abstract][Full Text] [Related]
7. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ
Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185
[TBL] [Abstract][Full Text] [Related]
8. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
9. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
Nahum A; Erhart A; Gazard D; Agbowai C; Van Overmeir C; van Loen H; Menten J; Akogbeto M; Coosemans M; Massougbodji A; D'Alessandro U
Malar J; 2007 Dec; 6():170. PubMed ID: 18154655
[TBL] [Abstract][Full Text] [Related]
10. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and drug resistance status of malaria parasite in northeast India.
Goswami D; Baruah I; Dhiman S; Rabha B; Veer V; Singh L; Sharma DK
Asian Pac J Trop Med; 2013 Jul; 6(7):583-8. PubMed ID: 23768834
[TBL] [Abstract][Full Text] [Related]
13. [The proper use of antimalarial drugs currently available].
Bourgeade A; Delmont J
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
[TBL] [Abstract][Full Text] [Related]
14. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Barnes KI; White NJ
Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
[TBL] [Abstract][Full Text] [Related]
15. Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum.
Trotta RF; Brown ML; Terrell JC; Geyer JA
Biochemistry; 2004 May; 43(17):4885-91. PubMed ID: 15109245
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Koram KA; Abuaku B; Duah N; Quashie N
Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
[TBL] [Abstract][Full Text] [Related]
17. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review.
Olliaro PL; Taylor WR
J Postgrad Med; 2004; 50(1):40-4. PubMed ID: 15047998
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Quashie NB; Duah NO; Abuaku B; Koram KA
Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
[TBL] [Abstract][Full Text] [Related]
20. The detection and treatment of Plasmodium falciparum malaria: time for change.
Nosten F; Ashley E
J Postgrad Med; 2004; 50(1):35-9. PubMed ID: 15047997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
